APGAVI

Serial Number 90165171
Registration 6998642
700

Registration Progress

Application Filed
Sep 8, 2020
Under Examination
Approved for Publication
Dec 27, 2022
Published for Opposition
Dec 27, 2022
Registered
Mar 14, 2023

Trademark Image

APGAVI

Basic Information

Serial Number
90165171
Registration Number
6998642
Filing Date
September 8, 2020
Registration Date
March 14, 2023
Published for Opposition
December 27, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 14, 2023
Registration
Registered
Classes
005

Rights Holder

ASCENTAGE PHARMA (SUZHOU) CO., LTD.

03
Address
68 XINQING ROAD
SUZHOU INDUSTRIAL PARK
SUZHOU 215000
CN

Ownership History

ASCENTAGE PHARMA (SUZHOU) CO., LTD.

Original Applicant
03
Suzhou, Jiangsu CN

ASCENTAGE PHARMA GROUP CORP LIMITED

Original Applicant
03
Hong Kong CN

ASCENTAGE PHARMA GROUP CORP LIMITED

Owner at Publication
03
Hong Kong CN

ASCENTAGE PHARMA (SUZHOU) CO., LTD.

Owner at Publication
03
Suzhou, Jiangsu CN

ASCENTAGE PHARMA (SUZHOU) CO., LTD.

Original Registrant
03
Suzhou, Jiangsu CN

ASCENTAGE PHARMA GROUP CORP LIMITED

Original Registrant
03
Hong Kong CN

ASCENTAGE PHARMA (SUZHOU) CO., LTD.

New Owner After Registration #1
03
SUZHOU CN

Legal Representation

Attorney
Kathryn E. Smith

USPTO Deadlines

Next Deadline
1325 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-03-14)
Due Date
March 14, 2029
Grace Period Ends
September 14, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

33 events
Date Code Type Description Documents
Apr 2, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Mar 14, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 14, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 27, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 27, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 7, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 21, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 21, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 20, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 20, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 9, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 9, 2022 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jun 9, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 18, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 18, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 17, 2022 ALIE A ASSIGNED TO LIE Loading...
May 12, 2022 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Nov 17, 2021 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Nov 17, 2021 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Nov 17, 2021 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Oct 27, 2021 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Apr 21, 2021 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Apr 21, 2021 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Apr 21, 2021 CNSL R SUSPENSION LETTER WRITTEN Loading...
Mar 31, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 30, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 30, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 6, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 6, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 6, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 5, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 13, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 11, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medicines for dental purposes; Chemical preparations for medical purposes for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Antibiotics; Injectable medicines for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Medicine in tablet form for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Drugs sold in bulk for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Antiseptics; Collyrium; Hemorrhoidal suppositories, laxative suppositories, or vaginal suppositories for the prevention and treatment of infections; Medical paster, namely, medical plasters; Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Medicated sweets; Candy for medical purposes; Dietetic foods adapted for medical purposes; Dietetic beverages adapted for medical purposes; Dietetic preparations adapted for medical purposes; Medicinal oils; Mineral food supplements; Nutritional supplements; Medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Bacterial poisons; Pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Radioactive substances for medical purposes; Gases for medical purposes, namely, nitric oxide for medical purposes; Chemical conductors for electrocardiograph electrodes; Semen for artificial insemination; Disinfectants; Solutions for contact lenses; Media for bacteriological cultures; Depuratives for the body; Diagnostic preparations for veterinary purposes; Pesticides; Sanitary napkins; Cotton for medical purposes; Dental abrasives; Diapers for pets

Classification

International Classes
005